EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Evidence of interferon production in the hamster lung after primary or secondary exposure to parainfluenza virus type 3


American Review of Respiratory Disease 125(6): 706-711
Evidence of interferon production in the hamster lung after primary or secondary exposure to parainfluenza virus type 3
Experimental infection of the hamster respiratory tract with parainfluenza virus type 3 has been used to study the pathogenesis of viral pneumonia and the host response to infection. In this study, hamsters inoculated intranasally with parainfluenza virus type 3 produced local interferon, which was detected in lung washes obtained by in situ lavage. Interferon activity was present as early as 2 days after infection, and titers correlated directly with the quantity of virus recovered in lung washes. Parainfluenza virus type 3 was sensitive to the antiviral state induced in vitro by the lung wash interferon. Infectious virus induced interferon in cultures of immune and nonimmune lung wash cells, primarily alveolar macrophages. A secondary response of immune, mixed cultures of lymphocytes and alveolar macrophages, stimulated with inactivated virus, produced low concentrations of interferon, perhaps type II. Lymphocyte-alveolar macrophage cultures produced a pH and temperature-sensitive interferon in response to mitogen induction, characteristics of type II or immune interferons in the human and murine systems. Interferon may be an early defense involved in recovery from primary infection with parainfluenza virus type 3, and may contribute to resistance to reinfection.


Accession: 005411529

PMID: 6178328

DOI: 10.1164/arrd.1982.125.6.706



Related references

Markers differentiating type 3 parainfluenza virus grown at 25 and 37 c cercopithecus monkey kidney tissue culture hamster interferon production hem agglutination inhibition antibodies. Applied Microbiology 17(4): 589-595, 1969

Growth of parainfluenza type 3 virus and interferon production in infant and adult mice. Brit J Exp Pathol 47(3): 235-241, 1966

Interferon production by monocyte macrophages in response to respiratory syncytial virus and parainfluenza type 3. Pediatric Research 19(4 PART 2): 298A, 1985

Bovine parainfluenza virus type 3 accessory proteins that suppress beta interferon production. Microbes and Infection 9(8): 954-962, 2007

Cell-mediated cytotoxicity: comparison of primary and secondary immune reactions after parainfluenza type 1 virus inoculation. Experimental Cell Biology 46(1-2): 11-30, 1978

Human parainfluenza virus type 2 V protein inhibits interferon production and signaling and is required for replication in non-human primates. Virology 397(2): 285-298, 2010

Protection from experimental wild type parainfluenza virus type 3 infection by cold adapted mutants of parainfluenza virus type 3 in weanling hamsters. Abstracts of the Annual Meeting of the American Society for Microbiology 85: 298, 1985

Protection of weanling hamsters from experimental infection with wild type parainfluenza virus type 3 by cold adapted mutants of parainfluenza virus type 3. Journal of Medical Virology 18(2): 131-138, 1986

Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. Journal of Virology 74(24): 11626-11635, 2000

Interferon production in children with respiratory syncytial virus influenza virus and parainfluenza virus infections. Journal of Pediatrics 93(1): 28-32, 1978